At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...

African entrepreneurs can now apply for the Plus Factor Grant Program, offering up to N1 million funding, mentorship, market ...

Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and systemic-therapy injury justify ongoing symptom reporting, CT/PFT ...

The methodology for selecting high-growth dividend-paying stocks focuses on dividend growth and sustainability than on high current yield. Check out the picks here.

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

In every industry, leadership teams are under pressure to deliver consistent growth in unpredictable conditions. Markets ...

Plus Incubation Hub has launched the Plus Factor Grant Programme, a high-impact, merit-based initiative designed to identify, nurture ...

"slightly offset by subscribers projected to be down seven percent year over year to 2,200,000." Management confirmed, "We ...

Filing acceptance based on phase III data showing giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, versus ...

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...

Thank you for attending the GoPro Fourth Quarter and Fiscal Year 2025 Earnings Call. My name is Cameron, and I'll be your moderator for today. [Operator Instructions]. I would now like to pass the ...

Analysts say rolling back regulations pushes US further towards petrol cars, discourages EV innovation, and gives China competitive edge ...